首页> 外文期刊>Clinical Pharmacology and Therapeutics >Genetic polymorphisms of glutathione S-transferase A1, the major glutathione S-transferase in human liver: consequences for enzyme expression and busulfan conjugation.
【24h】

Genetic polymorphisms of glutathione S-transferase A1, the major glutathione S-transferase in human liver: consequences for enzyme expression and busulfan conjugation.

机译:谷胱甘肽S-转移酶A1(人类肝脏中主要的谷胱甘肽S-转移酶)的遗传多态性:酶表达和白消安结合的后果。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

BACKGROUND: High-dose busulfan is widely used as part of conditioning regimens for patients who are undergoing hematopoietic stem cell or bone marrow transplantation. High plasma concentrations of busulfan have been linked to the occurrence of hepatic venoocclusive disease (VOD), a severe complication associated with a high mortality. Because conjugation with glutathione, the major route of biotransformation of busulfan, is predominantly catalyzed by the isozyme glutathione S-transferase A1 (GSTA1), we hypothesized that low expression or function of GSTA1 in liver caused by genetic polymorphisms may be the mechanism underlying VOD. METHODS: Immunoblot analysis of GSTA and measurement of busulfan-glutathione conjugation by liquid chromatography-mass spectrometry were performed in 48 normal human liver samples. To search for polymorphisms, the complete GSTA1 coding regions and the promoter fragment were sequenced. All results were compared by multivariate analysis. RESULTS: Absolute levels of GSTA protein and formation rates of busulfan-glutathione conjugate displayed a 7- and 8-fold range, from 240 to 1600 pmol/mg and 25 to 205 pmol/min per milligram of total cytosolic protein, respectively, and correlate (r2 = 0.49, P <.0001). A total of 8 single nucleotide polymorphisms (SNPs) of GSTA1 were identified, 1 of which was a silent mutation in exon 5 (A375G); all others were found in the promoter region. Haplotype analysis revealed the existence of 5 defined alleles. There was no significant relationship between any of the GSTA1 SNPs or haplotypes and either hepatic glutathione S-transferase A (GSTA) expression or GSTA1 function. CONCLUSIONS: The identified GSTA1 polymorphisms are not likely to be related to the VOD because they do not appear to be associated with changes in GSTA expression or function. Compared with other members of the GST family, GSTA1 displays surprisingly little variation.
机译:背景:大剂量白消安被广泛用作正在接受造血干细胞或骨髓移植的患者的调理方案。血浆白消安的高浓度与肝静脉闭塞性疾病(VOD)的发生有关,这是一种伴随高死亡率的严重并发症。因为与谷胱甘肽的结合是白消安生物转化的主要途径,主要由同工酶谷胱甘肽S-转移酶A1(GSTA1)催化,所以我们推测由遗传多态性引起的GSTA1在肝脏中的低表达或功能可能是VOD的潜在机制。方法:对48例正常人肝脏样品进行了GSTA的免疫印迹分析和液相色谱-质谱联用测定硫丹-谷胱甘肽的结合。为了搜索多态性,对完整的GSTA1编码区和启动子片段进行了测序。所有结果均通过多元分析进行比较。结果:GSTA蛋白的绝对水平和白消安-谷胱甘肽共轭物的形成速率分别为每毫克总胞质蛋白240至1600 pmol / mg和25至205 pmol / min的7倍和8倍,并且相关(r2 = 0.49,P <.0001)。总共鉴定出GSTA1的8个单核苷酸多态性(SNP),其中1个是第5外显子(A375G)的沉默突变;另外一个是GSTA1单核苷酸多态性。其他所有在启动子区域。单倍型分析显示存在5个定义的等位基因。没有任何GSTA1 SNP或单倍型与肝谷胱甘肽S-转移酶A(GSTA)表达或GSTA1功能之间存在显着关系。结论:确定的GSTA1多态性不太可能与VOD相关,因为它们似乎与GSTA表达或功能的改变无关。与GST家族的其他成员相比,GSTA1的变化令人惊讶。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号